Nicht aus der Schweiz? Besuchen Sie lehmanns.de
High Risk Cardiac Revascularization and Clinical Trials -

High Risk Cardiac Revascularization and Clinical Trials

Buch | Hardcover
592 Seiten
2002
CRC Press (Verlag)
978-1-84184-185-4 (ISBN)
CHF 317,70 inkl. MwSt
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken
Trials have been designed to test the success of therapies for patients with multi-vessel obstructive coronary artery disease, and to compare survival rates with those receiving surgical treatment. The compilation of information on outcomes of the high-risk patient is presented in this text.
Supported by over 100 illustrations, this text examines and compares medical and surgical management of cardiovascular disease for the high-risk cardiac patient. Incorporating comprehensive coverage of relevant trials (and the lessons learnt from them), and examining evolving medical technology (including drug therapy) and the long-term outcome of various forms of management, it is a valuable source of information for the interventional or non-invasive cardiologist, cardiac surgeon and trainee alike.

Section I: Is the Medical Management Optimal? Section II: The Benefits of Revascularization Section III: Comparative Trials of CABG Versus PCI Section IV: Differential Risks/Differential Benefits: Patient Subsets Section V: Comorbidity Section VI: Adding Value to the Revascularization Option Section VII: What Can be Done After the Revascularization to Discourage Recidivism? Section VIII: Medicine vs PCI vs CABG in 2001 for High-risk Unstable Angina

Erscheint lt. Verlag 1.8.2002
Verlagsort London
Sprache englisch
Gewicht 1746 g
Themenwelt Medizinische Fachgebiete Chirurgie Herz- / Thorax- / Gefäßchirurgie
Medizinische Fachgebiete Innere Medizin Kardiologie / Angiologie
ISBN-10 1-84184-185-4 / 1841841854
ISBN-13 978-1-84184-185-4 / 9781841841854
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Diagnostische und interventionelle Kathetertechniken

von Harald Lapp

Buch (2022)
Thieme (Verlag)
CHF 307,95